There is still time to book a place at EuroSciCon's 'Genomics and Chemical Space: a new Locus for Drug Discovery' meeting on 12th October 2007. Even though the early registration deadline has passed you can get 50% off the registration cost.
This meeting has a full agenda, with speakers from academia and industry. It and will be Chaired by Professor Sir Tom Blundell, Professor and Head of Biochemistry, Chair of the School of Biological Sciences, University of Cambridge.
Talks include:
Family-Based Structural Genomics for Targeting Binding Space Dr. Frank Von Delft, University of Oxford, UK
Chemical space and drug likeness Dr. Andrew Hopkins, Pfizer Sandwich, UK
High throughput fragment screening using X-ray crystallography Dr. Miles Congreve, Astex Therapeutics, UK
Physicochemical Property Trends in Drugs and Current Medicinal Chemistry Dr Paul Leeson, Astra Zeneca Charnwood
Fragment-based lead generation at AstraZeneca: Philosophy, strategy and some case studies Dr Alex Breeze, Global Structural Chemistry, AstraZeneca, UK
One simple step to sequencing secrets: The Roche Genome Sequencer FLX Dr Steve Baker, Roche Diagnostics Ltd
Fragments Professor Chris Abell, University of Cambridge, UK
The input of thermodynamic data to the drug development process Professor John Ladbury, UCL, UK
Drug Discovery: A finite problem Dr Colin R Groom, UCB, Cambridge
Book now by visiting www.regonline.com/genomics07 . Use this code, slect50dis to get 50% off the registration fee.
